“Rising Prevalence of Chronic Diseases”
One of the most significant drivers for the demand for injector pens is the rising prevalence of diabetes worldwide. The increasing number of diabetes cases, particularly Type 1 and Type 2 diabetes, has led to greater demand for devices like insulin injector pens, which require specialized polymers for their construction. The ease of use, convenience, and accuracy of these devices make them preferred over traditional syringes, driving the demand for high-quality polymers used in pens. Similarly, other chronic conditions such as rheumatoid arthritis, growth hormone deficiencies, and multiple sclerosis also require injectable treatments. The growing number of patients using injectable medications for these conditions is pushing the demand for injectable pens, which rely on advanced polymers for functionality, safety, and durability.
